Adenomatous Polyposis Coli clinical trials at UCSF
1 research study open to eligible people
Adenomatous polyposis coli is a genetic condition that causes many polyps in the colon and rectum. UCSF is testing a new drug in people with advanced or metastatic solid tumors. The study checks whether the drug is safe and effective.
Showing trials for
FOG-001 in Locally Advanced or Metastatic Solid Tumors
open to eligible people ages 18 years and up
The goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic cancer.
San Francisco, California and other locations
Last updated: